Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2012
12/27/2012CA2836927A1 Novel maytansinoid derivatives with peptide linker and conjugates thereof
12/26/2012EP2537850A1 Organic compounds
12/26/2012EP2537847A1 Polymorphs of dasatinib and process for preparation thereof
12/26/2012EP2537843A2 Preparation of maleate salt of neratininb and its use
12/26/2012EP2537834A2 Polyazamacrocyclic compound, and a production method and a biomedical use therefor
12/26/2012EP2537831A1 Imidazole derivative
12/26/2012EP2537533A2 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation
12/26/2012EP2537532A1 Cathepsin-binding compounds bound to a nanodevice and their diagnostic and therapeutic use
12/26/2012EP2537530A1 Radiation therapy agent
12/26/2012EP2537529A1 Lox and loxl2 inhibitors antibodies and uses thereof
12/26/2012EP2537517A1 Deuterium-enriched 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamide
12/26/2012EP2537031A1 Compositions and methods for treating cancer
12/26/2012EP2536748A1 Neuregulin antagonists and use thereof in treating cancer
12/26/2012EP2536741A2 Gene fusion targeted therapy
12/26/2012EP2536731A1 Substituted spiroindolinones
12/26/2012EP2536730A1 Pyrrolopyrimidine compounds as inhibitors of cdk4/6
12/26/2012EP2536729A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
12/26/2012EP2536728A1 Pyrazole derivatives as jak inhibitors
12/26/2012EP2536727A1 Deuterated pyrrolopyrimidine compounds as inhibitors of cdk4/6
12/26/2012EP2536726A1 Diaryl ether linked pyrrolo [2,1-c][1,4]benzodiazepine hybrids and process for the preparation thereof
12/26/2012EP2536725A1 Dihydropteridinones, method for production and use thereof
12/26/2012EP2536723A1 Pyrazolo piperidine derivatives as nadph oxidase inhibitors
12/26/2012EP2536722A1 Bicyclic compounds and their uses as dual c-src / jak inhibitors
12/26/2012EP2536720A1 Triazolo [4, 5 - b]pyridin derivatives
12/26/2012EP2536719A1 Heterocyclic compounds and uses as anticancer agents
12/26/2012EP2536714A2 A novel 5-membered heterocycle derivatives and manufacturing process thereof
12/26/2012EP2536708A2 Androgen receptor modulators and uses thereof
12/26/2012EP2536707A1 Process for the preparation of alpha form of imatinib mesylate
12/26/2012EP2536706A1 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
12/26/2012EP2536693A1 Substituted 2-imidazolidones and analogs
12/26/2012EP2536686A1 Cyclic keto-enols for therapy
12/26/2012EP2536431A2 Compositions and methods for inhibiting mmset
12/26/2012EP2536430A1 Compositions and methods for targeting type 1 interferon producing cells
12/26/2012EP2536414A1 Method for preventing cancer metastasis
12/26/2012EP2536407A2 Taxane pro-emulsion formulations and methods making and using the same
12/26/2012EP2536405A1 Non peptidic 14-3-3 inhibitors and the use thereof
12/26/2012EP2536403A1 Compositions comprising perfluorooctanoic acid
12/26/2012EP2536283A1 Phenyl-heteroaryl derivatives and methods of use thereof
12/26/2012EP2536279A1 Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate
12/26/2012EP2453017A9 Oligonucleotides for use in prophylaxis and/or treatment of TGF-beta1 and TGF-beta2, TGF-beta2 and TGF-beta3, TGF-beta1 and TGF-beta3, or TGF-beta1, TGF-beta2, and TGF-beta3 mRNA overexpressing diseases
12/26/2012CN102844443A Methods and compositions for the diagnosis and treatment of thyroid cancer
12/26/2012CN102844323A Cdk5 inhibitors and therapeutic uses thereof
12/26/2012CN102844320A 杂环化合物 Heterocyclic Compounds
12/26/2012CN102844317A Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
12/26/2012CN102844307A Triazole compounds as ksp inhibitors
12/26/2012CN102844300A Cyclic keto-enols for therapy
12/26/2012CN102844048A Pharmaceutical agent for treatment and/or prevention of cancer
12/26/2012CN102844031A Organic compound for use in the treatment of liver cancer
12/26/2012CN102844023A Cdc7 kinase inhibitors and uses thereof
12/26/2012CN102841200A Use of pIgR as molecular marker of early recurrence and/or metastasis of tumor and intervening target spot of anti-tumor metastasizing medicine
12/26/2012CN102839194A Recombinant adeno-associated virus vector, and preparation method and application thereof
12/26/2012CN102839192A miRNA (micro Ribonucleic Acid) absorption carrier, preparation method and uses thereof
12/26/2012CN102839187A miR-29 absorption sequence, absorption carrier and uses thereof
12/26/2012CN102839186A Preparation and application of recombinant Mycobacterium smegmatis expressing NY-ESO-1
12/26/2012CN102839181A Nucleic acid aptamer sequence of gastric cancer cells, and uses thereof
12/26/2012CN102838751A Amphiphilic block copolymer self-assembled micelle based on molecular glue and purpose thereof
12/26/2012CN102838687A Extraction method for beta-glucan in oat bran
12/26/2012CN102838679A Preparation and application of Her2-neu antigen positive tumor therapeutic vaccine
12/26/2012CN102838657A Human tumor marker TBRG4 (transforming growth factor beta regulator 4) polypeptide and application thereof
12/26/2012CN102838652A Oleanolic acid derivative with function of resisting malignant tumor, as well as preparation method and applications of oleanolic acid derivative
12/26/2012CN102838625A Tetrahydropyridothiazole compounds, preparation method, drug compositions containing the same, and uses thereof
12/26/2012CN102838610A Bisindole dioxabicyclo octanedione
12/26/2012CN102838601A Selective phosphatidylinositol-3 kinase delta inhibitor
12/26/2012CN102838600A Phenylquinazoline PI3Kdelta inhibitors
12/26/2012CN102838596A Pyrrolo[2,3-b]pyridine derivative, preparation method and application thereof
12/26/2012CN102838592A 2,4-diaryl thiazole derivative, and pharmaceutical composition, preparation method and application thereof
12/26/2012CN102838590A Amino quinazoline derivative and application thereof in preparation of antineoplastic drugs
12/26/2012CN102838567A Benzenesulfonyl piperazine compounds or benzoyl piperazine compounds, preparation methods and uses thereof
12/26/2012CN102838550A Quinolinylcrotyl compound and its application in preparation of anti-malignant tumor drugs
12/26/2012CN102838539A Quinolinylenamide derivative and its application in preparation of anti-malignant tumor drugs
12/26/2012CN102838536A 3-cyanopyridine derivative and preparation as well as application thereof
12/26/2012CN102838532A Novel compounds for a treatment of diseases associated with amyloid or amyloid-like proteins
12/26/2012CN102838530A Aloe emodin derivative and preparation method thereof
12/26/2012CN102838515A Cinnamoyl sulfonamide compound preparation and applications of cinnamoyl sulfonamide compounds in anti-tumor treatment drugs
12/26/2012CN102838465A New compound selaginellin M with anticancer activity, and uses thereof
12/26/2012CN102838464A New compound selaginellin N with anticancer activity, and uses thereof
12/26/2012CN102838460A Series of skin-whitening (lightening) compounds
12/26/2012CN102836446A In-vivo phase transition tumor targeted nanobubble, its preparation method and application
12/26/2012CN102836442A Application of DCX-SPRAC double-gene co-expression vector in preparation of radiotherapy sensitization agent
12/26/2012CN102836441A Method for enhancing immune response in treatment of infectious and malignant disease
12/26/2012CN102836437A Docetaxelpolyoxyethelene-polyoxypropylene-polyoxyethelene compound capable of self-assembling into micelle
12/26/2012CN102836436A Integrin receptor-targeted taxol nanocomposite and preparation method thereof
12/26/2012CN102836435A PH sensitive type liver-targeted compound nano drug delivery system based on sodium alginate and preparation method
12/26/2012CN102836434A Medicine-carrying biological glue and method for preparing same
12/26/2012CN102836430A Application of blocking antibody T5E3 to reversing of tumor multidrug resistance
12/26/2012CN102836420A Methods and compositions involving MDA-7
12/26/2012CN102836418A Pingyangmycin polyethylene glycol (PEG)-polycaprolactone (PCL)-polyethylene glycol (PEG) temperature-sensitive slow-release gel, as well as preparation method and application of same
12/26/2012CN102836415A Composition for enhancing immune activity, medical composition for preventing and improving cancer
12/26/2012CN102836408A Fagopyrum tataricum toxin expelling powder and preparation method thereof
12/26/2012CN102836405A Medicament for treating encephaloma
12/26/2012CN102836392A Liquid oral preparation for treating malignant tumor and preparation method
12/26/2012CN102836386A Traditional Chinese drug preparation for treating uterine fibroid (qi-stagnancy and blood stasis)
12/26/2012CN102836381A Preparation method and application of middle calming tablet
12/26/2012CN102836369A Traditional Chinese medicine decoction for treating middle-late lung cancers
12/26/2012CN102836359A Medicine for treating ovarian cyst
12/26/2012CN102836326A White lucid ganoderma traditional Chinese drug composition and preparation method thereof
12/26/2012CN102836315A Chinese medicinal composition for preventing and conditioning prognosis tumors and preparation method thereof
12/26/2012CN102836261A Application of kidney-tonifying capsules in preparing medicament for inhibiting MDA-MB-157 cell proliferation
12/26/2012CN102836236A Ultrahigh-pressure extraction method of hovenia dulcis general flavone
12/26/2012CN102836222A Black lucid ganoderma traditional Chinese drug composition and preparation method thereof
1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 2211